Article: Nicotinamide Riboside Prevents Low Kidney Nephron Numbers Caused by Maternal Protein Restriction: Preclinical Findings

PrevNext
Kidney Disease Kidney Health Preclinical Reproductive Health

Nicotinamide Riboside Prevents Low Kidney Nephron Numbers Caused by Maternal Protein Restriction: Preclinical Findings

Synopsis

Babies born with fewer nephrons (kidney filters), often due to poor maternal nutrition, have higher risk for kidney disease and high blood pressure later. There are no current treatments to increase nephron numbers. This study showed that in mice born to mothers on a low-protein diet, kidney SIRT3 (a protective enzyme) levels were low, and nephron number was reduced. Giving nicotinamide riboside (NR), a NAD+ precursor that activates SIRT3, restored SIRT3 levels and activity, improved kidney structure, and protected mitochondria from damage. These findings suggest that boosting SIRT3 with NR during kidney development could prevent nephron loss and its long-term health effects.

Journal

Cells

Share

Read more

Neurological Health

NAD+ Depletion Triggers SARM1 Activation and Cell Death, Prevented by PARP Inhibitors: Preclinical Findings

SynopsisSarm1 is a protein that drives programmed axon degeneration by breaking down NAD⁺, but its activity is controlled by NAD+ levels. This study found that in cells treated with the mitochondri...

Read more
Healthy Aging & Longevity

Comparison of Metformin and Nicotinamide Riboside in Reducing Tissue Aging: Preclinical Findings

SynopsisMetformin (MET) and nicotinamide riboside (NR) both have potential anti-aging effects, but how they work in different tissues isn't fully clear. This study showed that MET and NR reduce sig...

Read more